APA (7th ed.) Citation

Pidanicova, A., Dobrota, D., Kliment, J., Petrovicova, J., Valanský, L., Kmeťová Sivoňová, M., . . . LACHVAC. Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer.

Chicago Style (17th ed.) Citation

Pidanicova, A., Dušan Dobrota, Ján Kliment, J. Petrovicova, Ladislav Valanský, Monika Kmeťová Sivoňová, M. Tajtakova, V. Nagy, and LACHVAC. Serum Level of IGFBP3 and IGF1/IGFBP3 Molar Ratio in Addition to PSA and Single Nucleotide Polymorphism in PSA and CYP17 Gene May Contribute to Early Diagnostics of Prostate Cancer.

MLA (9th ed.) Citation

Pidanicova, A., et al. Serum Level of IGFBP3 and IGF1/IGFBP3 Molar Ratio in Addition to PSA and Single Nucleotide Polymorphism in PSA and CYP17 Gene May Contribute to Early Diagnostics of Prostate Cancer.